ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer.

Tina Cascone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.